Clinical Trial Update: INDUCE: A Prospective 2-Year Spine Registry

View source ↗

Summary

This clinical trial update describes an ongoing prospective 2-year spine registry (INDUCE) sponsored by Red Rock Regeneration Inc., enrolling by invitation to e…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Degenerative Disc Disease

Drugs mentioned

• NMP (NMP)

Snippet

Sponsor: Red Rock Regeneration Inc. | Conditions: Subjects Treated With NMP as Part of Their Spine Surgery, Degenerative Disc Disease (DDD) | Status: ENROLLING_BY_INVITATION